Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05289856
Title Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Johannes Gutenberg University Mainz
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.